Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

Circulation

Volumn 94, Issue 7, 1996, Pages 1528-1536

  Abdelmeguid, Alaa E ^a,b   Topol, Eric J ^a   Whitlow, Patrick L ^a   Sapp, Shelly K ^a   Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

angioplasty; creatine kinase; enzymes; revascularization

Indexed keywords

CREATINE KINASE MB;

ADULT; ARTICLE; ATHERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029783646     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1528     Document Type: Article

References (49)

1. Dillon MC, Calbreath DF, Dixon AM, Rivin BE, Roark SF, Ideker RE, Wagner GS. Diagnostic problems in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels. Arch Intern Med. 1982;142:33-38.
2. Petterson T, Ohlsson O, Tryding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarction: a risk indicator of coronary death. Eur Heart J. 1992;13:1387-1392.
3. Ravkilde J, Hansen AB, Horder M, Jorgensen PJ, Thygesen K. Risk stratification in suspected acute myocardial infarction based on sensitive immunoassay for serum creatine kinase isoenzyme MB. Cardiology. 1992;80:143-151.
4. White RD, Grande P, Califf L, Palmeri ST, Califf RM, Wagner GS. Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction. Am J Cardiol. 1985;55:1478-1484.
5. Klein LW, Kramer BL, Howard E, Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 1991;17:621-626.
6. Oh JK, Snub C, Ilstrup DM, Reeder GS. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J. 1985;109:1225-1231.
7. Ravkilde J, Nissen H, Mickley H, Andersen PE, Thayssen P, Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J. 1994;127:13-20.
8. Spadaro JJ, Ludbrook PA, Tiefenbrunn AJ, Kurnik PB, Jaffe AS. Paucity of subtle myocardial injury after angioplasty delineated with MB CK. Cathet Cardiovasc Diagn. 1986;12:230-234.
9. Pauletto P, Piccolo D, Scannapieco G, Vescovo G, Zaninotto M, Corbara F, Cuman G, Chioin R, Casiglia E, Maddalena F, Pessina AC, Palu C. Changes in myoglobin, creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol. 1987;59:999-1000.
10. Kugelmass AD, Cohen CJ, Moscucci M, Piana RN, Senerchia C, Kuntz RE, Baim DS. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 1994;74;748-754.
11. Ellis SG, Roubin GS, King SB, Douglas JS, Weintraub WS, Thomas RG, Cox WR. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 1988;77: 372-379.
12. Detre KM, Holmes DR, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, Dorros GR, Bentivoglio LG. Kent KM, Myler RK. Incidence and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute PTCA Registry. Circulation. 1990;82:739-750.
13. Hinohara T, Rowe MH, Robertson GC, Selmon MR, Braden L, Legget JH, Vetter JW, Simpson JS. Effect of lesion characteristics on outcome of directional coronary atherectomy. J Am Coll Cardiol. 1991;17:1112-1120.
14. Hinohara T, Selmon MR, Robertson GC, Braden L, Simpson JS. Directional atherectomy: new approaches for treatment of obstructive coronary and peripheral vascular disease. Circulation. 1990;81(suppl IV):IV-79-TV-91.
15. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE). Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand J Clin Lab Invest. 1979;39:1-5.
16. Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, Detre K, Gosselin AJ, Gruentzig AR, Keley SF, Kent KM, Mock MB, Mullin SM, Myler RK, Passamani ER, Stertzer SH, Williams DO. PTCA: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. 1983;67: 723-730.
17. Ellis SG, De Cesare NB, Pinkerton CA, Whitlow P, King SB, Ghazzal ZMB, Kereiakes DJ, Popma JJ, Menke KK, Topol EJ, Holmes DR. Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy. Circulation. 1991;84:644-653.
18. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990;82:1193-1202.
19. Mehta CR, Patel NR. A network algorithm for performing Fisher's Exact Test in r x c contingency tables. J Am Stat Assoc. 1983;78: 427-434.
20. McCullagh P. Regression models for ordinal data (with discussion). J R Stat Soc. 1980;B42:109-142.
21. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
22. Sobel BE, Shell WE. Serum enzyme determination in the diagnosis and assessment of myocardial infarction. Circulation. 1972;45: 471-482.
23. Ahmed SA, Williamson JR, Roberts R, Clark RE, Sobel BE. The association of increased plasma MB CPK activity and irreversible ischemic myocardial injury in the dog. Circulation. 1976;54: 187-193.
24. Geft IL, Fishbein MC, Ninomiya K, Hashida J, Chaux E, Yano J, Y-Rit J, Genov T, Shell W, Ganz W. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation. 1982;66:1150-1153.
25. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest. 1971;50:2614-2625.
26. Shell WE, Sobel BE. Biochemical markers of ischemic injury. Circulation. 1976;53(suppl I):I-98-I-106.
27. Varal MA, Mercer DW. Cardiac specific creatine phosphokinase isoenzyme in the diagnosis of acute myocardial infarction. Circulation. 1975;51:855-859.
28. Mercer DW, Varat MA. Detection of cardiac specific creatine kinase isoenzyme in sera with normal or slightly increased total creatine kinase activity, din Chem. 1975;21:1088-1092.
29. D'Souza JP, Sine HE, Horvitz RA, Kubasik NP, Brody BB, Barold SS. The significance of the MB isoenzyme in patients with acute cardiovascular disease with a normal or borderline CPK activity. Clin Biochem. 1978;11:204-209.
30. Grande P, Christiansen C, Naestoft J. Creatine kinase isoenzyme MB assay by electrophoresis. Scan J Clin Lab Invest. 1979;39:607-612.
31. Grande P, Christiansen C, Pederson A, Christiansen MS. Optimal diagnosis in acute myocardial infarction: a cost-effectiveness study. Circulation. 1980;:61:723-728.
32. Shell WE, Kligerman M, Porke MP, Burnam M. Sensitivity and specificity of MB creatine kinase activity determined by column chromatography. Am J Cardiol. 1979;44:67-75.
33. Heyndrickx GR, Amano J, Kenna T, Fallon JT, Patrick TA, Manders T, Rogers GG, Rosendorff C, Vatner SF. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol. 1985;6:1299-1303.
34. Talasz H, Genser N, Mair J, Dworzak EA, Friedrich G, Moes N, Muhlberger V, Puschendorf B. Side-branch occlusion during percutaneous transluminal coronary angioplasty. Lancet. 1992;339:13801382.
35. Abdelmeguid AE, Ellis SE, Sapp SK, Simpfendorfer C, Franco I, Whitlow PL. Directional coronary atherectomy in unstable angina. J Am Coll Cardiol. 1994;24:46-54.
36. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hoffling B, Simonton CA, Masden RR, Serruys PW, Leon MB, Williams DO, King SB, Mark DB, Isner JM, Holmes DR, Ellis SG, Lee KL, Keeler GP, Berdan LG, Hinohara T, Califf RM. A comparison of directional atherectomy with coronary angioplasty in patients with coronary disease. N Engl J Med. 1993;329:221-227.
37. Waksman R, Scott NA, Douglas JS, Mays R, Peterson J, King SB. Distal embolization is common after directional atherectomy in coronary arteries and vein grafts. Circulation. 1993;88(suppl I):I-299, Abstract.
38. Garratt KN, Hinohara T. Complication rates: directional atherectomy versus coronary angioplasty: the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). Circulation. 1993;88(suppl I):I-586. Abstract.
39. Gaul G, Hollman J, Simpfendorfer C, Franco I. Acute occlusion in multiple lesion coronary angioplasty: frequency and management. J Am Coll Cardiol. 1989;13:283-288.
40. Altmann DB, Popma JJ, Hong MK, Salter LF, Pichard AD, Kent KM, Leon MB. CK-MB elevation after angioplasty of saphenous vein grafts. J Am Coll Cardiol. 1993;21:232A. Abstract.
41. Tauke IT, Kong TO, Meyers SN, Srinivisan G, Niemyski PR, Parker MA, Davidson CJ. Prognostic value of creatine kinase elevation following elective coronary artery interventions. J Am Coll Cardiol. 1995:269A. Abstract. Special issue.
42. Harrington RA, Lincoff AM, Califf RM, Holmes DR, Berdan L, O'Hanesian MA, Keeler GP, Garratt KN, Ohman EM, Mark DB, Jacobs AK, Topol EJ. Characteristics and consequences of myocardial infarction after percutaneous coronary interventions: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol. 1995;25:1693-1699.
43. Jacobey JA, Taylor WJ, Smith GT, Gorlin R, Harken DE. A new therapeutic approach to acute coronary occlusion. Am J Cardiol. 1962;9:60-73.
44. Euler DE, Prood CE, Spear JF, Moore EN. The interruption of collateral blood flow to the ischemic myocardium by embolization of a coronary artery with latex: effects on conduction delay and ventricular arrhythmias. Circ Res. 1981;49:97-108.
45. Marcus E, Katz LN, Pick R, Stamler J. The production of myocardial infarction, chronic coronary insufficiency and chronic coronary heart disease in the dog. Acta Cardiol. 1958;13:190-198.
46. Kaplinsky E, Ogawa S, Balke W, Dreifus L. Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circulation. 1979;60:397-403.
47. Pogwizd SM. Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy. Circulation. 1994; 90:1141-1158.
48. Lipsitz LA, Pluchino FC, Wei JY. The prevalence and prognosis of minimally elevated creatine kinase-myocardial band activity in elderly patients with syncope. Arch Intern Med. 1987;147:1321-1323.
49. Heller GV, Blaustein AS, Wei JY. Implications of increased myocardial isoenzyme level in the presence of normal serum creatine kinase activity. Am J Cardiol. 1983;51:24-27.